Application no. and date | 15189714.7 (espacenet) (Federated) (European Patent Register), 20081121 | Patent/reg. no. and date | DK/EP 3002298, 20190828 | Publication date | 20160406 | Priority no. and date | US 989523 P, 20071121 | EP pub. no. and date |
EP 3002298 20160406 | Effective date | | Applicant/owner | Oregon Health & Science University, 3181 SW Sam Jackson Park Road
Portland, OR 97239, US, Vanderbilt University, Office of Technology Transfer and Enterprise Development 305 Kirkland Hall
Nashville, TN 37240, US | Applicant ref. no. | P81904503DK00E | Inventor | GAILANI, David, 2361 Wimbledon Circle
Franklin, TN 37069, US, GRUBER, Andras, 3500 SW Bridlemile Land
Portland, OR 97221, US, HANSON, Stephen, Raymond, 16922 NW Hazelgrove Court
Beaverton, OR 97006, US, TUCKER, Erik, Ian, 1511 SW Park Avenue, Apt. 1307
Portland, OR 97201, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 16/36 (2006.01) | Title | ANTI-FAKTOR XI MONOKLONALE ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|